All Stories

  1. Medikamentöse Behandlung der CED

    Article • Therapeutische Umschau, December 2018, Hogrefe Publishing Group

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  2. The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease

    Article • Journal of Crohn s and Colitis, November 2015, Oxford University Press (OUP)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  3. Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease

    Article • Inflammatory Bowel Diseases, November 2015, Wolters Kluwer Health

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  4. High Rates of Smoking Especially in Female Crohn’s Disease Patients and Low Use of Supportive Measures to Achieve Smoking Cessation—Data from the Swiss IBD Cohort Study

    Article • Journal of Crohn s and Colitis, June 2015, Oxford University Press (OUP)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat, Roland von Känel

  5. Tu1294 Measurement of Functional Blocade of TNF-Alpha by Anti-TNF Agents Is a Stronger Predictor Than Trough Levels and Anti-Drug Antibodies: 2-Year Prospective Clinical Data

    Article • Gastroenterology, April 2015, Elsevier

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  6. Factors Associated with Durable Response to Infliximab in Crohnʼs Disease 5 Years and Beyond

    Article • Inflammatory Bowel Diseases, January 2015, Wolters Kluwer Health

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  7. The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients

    Article • Journal of Crohn s and Colitis, November 2014, Oxford University Press (OUP)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  8. Tu1180 Alcohol Consumption Within the Swiss IBD Cohort Study

    Article • Gastroenterology, May 2014, Elsevier

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  9. Su1414 Efficacy and Safety of Sequential Rescue Treatments in Steroid Refractory Ulcerative Colitis Experience

    Article • Gastroenterology, May 2014, Elsevier

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  10. The accuracy of self-reported medical history: A preliminary analysis of the promise of internet-based research in Inflammatory Bowel Diseases

    Article • Journal of Crohn s and Colitis, May 2014, Oxford University Press (OUP)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  11. Sa1238 CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNFAlpha in Anti-TNF Treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives

    Article • Gastroenterology, May 2014, Elsevier

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  12. P644 Alcohol consumption within the Swiss IBD Cohort Study

    Article • Journal of Crohn s and Colitis, February 2014, Oxford University Press (OUP)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  13. P423 Long term outcome for sequential rescue treatments in steroid refractory ulcerative colitis – a real life experience

    Article • Journal of Crohn s and Colitis, February 2014, Oxford University Press (OUP)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  14. DOP060 CD62L (L-selectin) shedding for assessment of functional blockade of TNF alpha in anti-TNF treated inflammatory bowel disease patients: clinical feasibility and perspectives

    Article • Journal of Crohn s and Colitis, February 2014, Oxford University Press (OUP)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  15. Novel Nonbiologic Therapies for Ulcerative Colitis

    Article • January 2014, Springer Science + Business Media

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  16. Efficacy and Safety of Natalizumab in Crohn’s Disease Patients Treated at 6 Boston Academic Hospitals

    Article • Inflammatory Bowel Diseases, October 2013, Wolters Kluwer Health

    Dr Adam S Cheifetz, Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  17. 950 Factors Associated With Durable Response to Infliximab 5 Years and Beyond: A Multi Center International Cohort

    Article • Gastroenterology, May 2013, Elsevier

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  18. Su1211 Comparative Long-Term Outcomes of Tacrolimus, Cyclosporine and Infliximab for Steroid-Refractory Ulcerative Colitis - Week 52 Results Swiss IBD Cohort Study

    Article • Gastroenterology, May 2013, Elsevier

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  19. P383 Response rates and side effects after 26 weeks of tacrolimus, infliximab or cyclosporine in patients with steroid refractory ulcerative colitis – Swiss IBD cohort study

    Article • Journal of Crohn s and Colitis, February 2013, Oxford University Press (OUP)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  20. Quality of life: a potentially useful measure to indicate subclinical flares in Crohn disease

    Article • Internal Medicine Journal, July 2012, Wiley

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat, Roland von Känel

  21. Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease

    Article • Alimentary Pharmacology & Therapeutics, June 2012, Wiley

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  22. Sa1915 Comparative Short-Term Response and Remission Rates for Tacrolimus, Cyclosporine and Infliximab for Steroid-Refractory Ulcerative Colitis

    Article • Gastroenterology, May 2012, Elsevier

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  23. P297 Efficacy and safety of natalizumab in Crohn's disease patients treated at six academic Boston hospitals

    Article • Journal of Crohn s and Colitis, February 2012, Oxford University Press (OUP)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  24. Strategies for the Prevention of Postoperative Recurrence in Crohn's Disease: Results of a Decision Analysis

    Article • The American Journal of Gastroenterology, July 2011, Nature

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  25. Meta-analysis: Diagnostic Performance of Low-Radiation-Dose Coronary Computed Tomography Angiography

    Article • Annals of Internal Medicine, March 2011, American College of Physicians

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  26. Infliximab for Crohnʼs disease in the Swiss IBD Cohort Study

    Article • European Journal of Gastroenterology & Hepatology, November 2010, Wolters Kluwer Health

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat, Roland von Känel

  27. Appropriateness of therapy for fistulizing Crohn’s disease: findings from a national inflammatory bowel disease cohort

    Article • Alimentary Pharmacology & Therapeutics, August 2010, Wiley

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat, Roland von Känel

  28. Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohort

    Article • Scandinavian Journal of Gastroenterology, July 2010, Taylor & Francis

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  29. Cohort Profile: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS)

    Article • International Journal of Epidemiology, May 2010, Oxford University Press (OUP)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  30. W1017 How Do IBD Patients Search for Information on Their Disease? Findings Within a National Clinical Cohort Study

    Article • Gastroenterology, May 2010, Elsevier

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  31. 42 Appropriateness of Therapy for Fistulizing Crohn's Disease: Findings From a Nationwide Inflammatory Bowel Disease Cohort

    Article • Gastroenterology, May 2010, Elsevier

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  32. The Effect of Nonmedical Factors on Variations in the Performance of Colonoscopy Among Different Health Care Settings

    Article • Medical Care, February 2010, Wolters Kluwer Health

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  33. Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel — EPACT II

    Article • Journal of Crohn s and Colitis, December 2009, Oxford University Press (OUP)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  34. Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel — EPACT II

    Article • Journal of Crohn s and Colitis, December 2009, Oxford University Press (OUP)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  35. Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel—EPACT II

    Article • Journal of Crohn s and Colitis, December 2009, Oxford University Press (OUP)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  36. Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel—EPACT II

    Article • Journal of Crohn s and Colitis, December 2009, Oxford University Press (OUP)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  37. Angemessener Einsatz der Koloskopie in Europa (EPAGE II)

    Article • Endoskopie heute, June 2009, Thieme Publishing Group

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  38. Der angemessene Einsatz der Koloskopie in Europa (EPAGE II)

    Article • Endoskopie heute, June 2009, Thieme Publishing Group

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  39. Corrigendum to “Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study” [J. Crohn's & Colitis (2008) 2, 131–141]

    Article • Journal of Crohn s and Colitis, June 2009, Oxford University Press (OUP)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  40. S1027 Which Drugs Are Safe in Male and Female Patients Considering Conception, and in Pregnant Women and Nursing Mothers, with Crohn's Disease? Results of a Multidisciplinary International Expert Panel (EPACT II)

    Article • Gastroenterology, May 2009, Elsevier

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  41. S1028 Appropriate Maintenance Treatment for Crohn's Disease: Results of a Multidisciplinary International Expert Panel - EPACT II

    Article • Gastroenterology, May 2009, Elsevier

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  42. W1219 Appropriateness of Therapy for Active Crohn's Disease: Results of a Multidisciplinary International Expert Panel (EPACT II)

    Article • Gastroenterology, May 2009, Elsevier

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  43. IBD and Chronic Diarrhea: When Is Colonoscopy Appropriate?

    Article • Gastrointestinal Endoscopy, April 2009, Elsevier

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  44. Appropriateness of colonoscopy in Europe (EPAGE II)

    Article • Endoscopy, March 2009, Thieme Publishing Group

    Dr Vicente Lorenzo-Zúñiga García, Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  45. Appropriateness of colonoscopy in Europe (EPAGE II)

    Article • Endoscopy, March 2009, Thieme Publishing Group

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  46. Appropriateness of colonoscopy in Europe (EPAGE II)

    Article • Endoscopy, March 2009, Thieme Publishing Group

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  47. P.291 Cohorte suisse des maladies inflammatoires chroniques de l’intestin (Swiss IBD Cohort Study) : premiers résultats issus du questionnaire médical d’inclusion

    Article • Gastroentérologie Clinique et Biologique, March 2009, Elsevier

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  48. Appropriateness of colonoscopy in Europe (EPAGE II)

    Article • Endoscopy, March 2009, Thieme Publishing Group

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  49. Appropriateness of colonoscopy in Europe (EPAGE II)

    Article • Endoscopy, March 2009, Thieme Publishing Group

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  50. Cohort Profile: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS)

    Article • International Journal of Epidemiology, September 2008, Oxford University Press (OUP)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat, Roland von Känel

  51. Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study

    Article • Journal of Crohn s and Colitis, June 2008, Oxford University Press (OUP)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  52. T1058 Appropriateness of Initial Treatment for Severe Crohn's Disease: Application of EPACT Criteria to the EC-IBD European Cohort

    Article • Gastroenterology, April 2008, Elsevier

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  53. P125 APPROPRIATENESS OF INITIAL TREATMENT FOR SEVERE CROHN'S DISEASE: APPLICATION OF EPACT CRITERIA TO THE EC-IBD EUROPEAN COHORT

    Article • Journal of Crohn s and Colitis Supplements, February 2008, Oxford University Press (OUP)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  54. P215 THE SWISS INFLAMMATORY BOWEL DISEASE COHORT STUDY (SIBDCS): FOUNDING AND FIRST OBSERVATIONS

    Article • Journal of Crohn s and Colitis Supplements, February 2008, Oxford University Press (OUP)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  55. P230 SWISS IBD COHORT STUDY (SIBDCS): PRELIMINARY RESULTS FROM PHYSICIAN ENROLLMENT QUESTIONNAIRES

    Article • Journal of Crohn s and Colitis Supplements, February 2008, Oxford University Press (OUP)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  56. EPACT II: Project and Methods

    Article • Digestion, January 2007, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  57. Upper Gastrointestinal Crohn’s Disease

    Article • Digestion, January 2007, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  58. Evaluating Appropriateness of Treatment for Crohn’s Disease: Feasibility of an Explicit Approach

    Article • Digestion, January 2007, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  59. Severe and Steroid-Resistant Crohn’s Disease

    Article • Digestion, January 2007, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  60. Pregnancy and Breastfeeding in Patients with Crohn’s Disease

    Article • Digestion, January 2007, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  61. Mild-to-Moderate Active Luminal Crohn’s Disease

    Article • Digestion, January 2007, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  62. Fistulizing Crohn’s Disease

    Article • Digestion, January 2007, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  63. Maintenance of Medically Induced Remission of Crohn’s Disease

    Article • Digestion, January 2007, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  64. Fibrostenotic Crohn’s Disease

    Article • Digestion, January 2007, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  65. Maintenance of Surgically Induced Remission of Crohn’s Disease

    Article • Digestion, January 2007, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  66. Drug Safety in Crohn’s Disease Therapy

    Article • Digestion, January 2007, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  67. Extraintestinal Manifestations of Crohn’s Disease

    Article • Digestion, January 2007, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  68. Infliximab for the Treatment of Disseminated Pyoderma Gangrenosum Associated with Ulcerative Colitis

    Article • Dermatology, January 2007, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  69. Appropriate Treatment for Crohn’s Disease: Methodology and Summary Results of a Multidisciplinary International Expert Panel Approach – EPACT

    Article • Digestion, January 2006, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  70. Extraintestinal Manifestations of Crohn’s Disease

    Article • Digestion, January 2005, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  71. Treatment of Gastroduodenal Crohn’s Disease

    Article • Digestion, January 2005, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  72. Drug Safety in the Treatment of Crohn’s Disease

    Article • Digestion, January 2005, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  73. Therapy of Mild to Moderate Luminal Crohn’s Disease

    Article • Digestion, January 2005, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  74. Fistulizing Crohn’s Disease

    Article • Digestion, January 2005, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  75. Obstructive Fibrostenotic Crohn’s Disease

    Article • Digestion, January 2005, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  76. Pregnancy and Crohn’s Disease

    Article • Digestion, January 2005, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  77. Severe and Steroid-Resistant Crohn’s Disease

    Article • Digestion, January 2005, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  78. Maintenance of Remission in Crohn’s Disease

    Article • Digestion, January 2005, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  79. Treatment of Postoperative Crohn’s Disease

    Article • Digestion, January 2005, Karger Publishers

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat

  80. Recent Literature A Guide to the Clinical Examination of Patients and the Diagnosis of Disease . By Richard Hagen, M. D., Privat docent to the University of Leipsic. Translated from the second revised and enlarged edition by G. E. Gramm, M. D. Philadelphi

    Article • May 1881, New England Journal of Medicine (NEJM/MMS)

    Privat Docent, Master of Science in Epidemiology Pascal Juillerat